OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 48 filers reported holding OVID THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $29,000 | -25.6% | 16,253 | 0.0% | 0.00% | – |
Q4 2018 | $39,000 | -78.8% | 16,253 | -50.0% | 0.00% | – |
Q3 2018 | $184,000 | +44.9% | 32,506 | +100.0% | 0.00% | – |
Q2 2018 | $127,000 | +111.7% | 16,253 | +168.1% | 0.00% | – |
Q4 2017 | $60,000 | +15.4% | 6,063 | 0.0% | 0.00% | – |
Q3 2017 | $52,000 | -18.8% | 6,063 | 0.0% | 0.00% | – |
Q2 2017 | $64,000 | – | 6,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
XTX Topco Ltd | 50,569 | $198,000 | 0.07% |